Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/07/2003US20030148928 Enzymatic nucleic acid peptide conjugates
08/07/2003US20030148927 Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
08/07/2003US20030148925 Insulin formulation for inhalation
08/07/2003US20030148924 Methods and pharmaceutical compositions of healing wounds
08/07/2003US20030148923 Obtained by treating fish meat (sardine) with alkaline protease, then eluting peptide-adsorbing resin with ethanol; hypotensive agents; health food; for reducing blood pressure
08/07/2003US20030148920 For inhibiting tumor-induced angiogenesis; antiischemic agents
08/07/2003US20030148516 Medium containing flt3 ligand for culturing hematophoietic cells
08/07/2003US20030148513 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
08/07/2003US20030148511 Induction of immunity using inhibitors of granzymes
08/07/2003US20030148507 RNA interference mediated inhibition of prostaglandin D2 receptor (PTGDR) and prostaglandin D2 synthetase (PTGDS) gene expression using short interfering RNA
08/07/2003US20030148500 Transcription factor
08/07/2003US20030148493 Sialidase and recombinant cell lines
08/07/2003US20030148491 Comprises receptor-like protein tyrosine phosphatase polypeptides (DEP-1) for use as antiinflammatory/anticarcinogenic agents
08/07/2003US20030148467 Comprises cytokine protein for treating fever, inflammation, cachexia and cancer
08/07/2003US20030148465 Comprises membrane protein for diagnosis and treatment of atherosclerosis, viral and inflammatory diseases
08/07/2003US20030148463 Novel method for the production of anti-human antigen receptors and uses thereof
08/07/2003US20030148460 Phosphodiester alpha-GlcNAcase of the lysosomal targeting pathway
08/07/2003US20030148458 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/07/2003US20030148457 Monkey and canine melanin concentrating hormone receptors
08/07/2003US20030148451 Endothelial differntiation gene 6-like g protein coupled receptor
08/07/2003US20030148449 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same
08/07/2003US20030148445 Comprises tumor necrosis factor ligand (TALL-1) and transmembrane polypeptide expressed in monocytes/macrophage for treatment of autoimmune diseases; antiproliferative agents
08/07/2003US20030148439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148438 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148436 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148435 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148434 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148433 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148432 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148430 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148427 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148426 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148425 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148424 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148423 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis
08/07/2003US20030148419 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148414 Comprises extracellular bacterial autoinducer-2 signalling molecule (such as 4,5-dihydroxy-2,3-pentanedione or homocysteine) which stimulates LuxQ bioluminescent proteins/ genes in Vibrio harveyi operon bioassay
08/07/2003US20030148398 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
08/07/2003US20030148397 Identifying bactericidal or microbiocidal amino acid sequences
08/07/2003US20030148396 Comprises p65 binding polypeptide (RAI) for diagnosis and treatment of adult respiratory distress syndrome, asthma, allograft rejection, cancer and inflammatory/autoimmune/vasoreconstrictive diseases
08/07/2003US20030148394 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058, or 6351 molecules
08/07/2003US20030148392 Using immunoassy to screen moulators of brain protein expression in cells; treating Alzheimer's disease/brain disorders; drug screening
08/07/2003US20030148382 PanCAM nucleic acids and polypeptides
08/07/2003US20030148378 Phosphodiesterase 10
08/07/2003US20030148376 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148375 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148373 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148371 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/07/2003US20030148370 Comprises nucleotide sequences coding membrane protein/pro-polypeptide; antitumor agents; drug screening
08/07/2003US20030148355 Gene expression levels indicate sleep disorders
08/07/2003US20030148351 Glycoproteins; antifibrotic agents; for regulating the growth of endothelial cells and angiogenesis, regulating or inhibiting growth of cancer cells, and regulating functions of neuromuscular junctions
08/07/2003US20030148336 Polymorphic marker that can be used to assess the efficacy of interferon therapy
08/07/2003US20030148331 Novel human hepatoma associated protein and the polynucleotide encoding said polypeptide
08/07/2003US20030148323 Analyzing nucleic acid and determining presence of mutant alleles encoding a protein with reduced activity/thermal stability; useful in diagnosing schizophrenia
08/07/2003US20030148317 Isolated polypeptide of given sequence; use in differentiation of monocytes and as a anti-proliferative agent for lung tumor cells
08/07/2003US20030148312 Measuring the expression level of MAL gene; atopic dermatitis and bronchial asthma
08/07/2003US20030148306 Aggrecanase molecules
08/07/2003US20030148305 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
08/07/2003US20030148294 DNA encoding novel chemokine receptors
08/07/2003US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein
08/07/2003US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions
08/07/2003US20030148262 Chimeric alphavirus replicon particles
08/07/2003US20030147966 Nanoparticle delivery vehicle
08/07/2003US20030147954 Cyclosporin and a release modifier encapsulated in a biodegradable polymer
08/07/2003US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2
08/07/2003US20030147911 Fusion proteins of mycobacterium tuberculosis antigens and their uses
08/07/2003US20030147910 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
08/07/2003US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture
08/07/2003US20030147905 Administering an oligopeptide for immunotherapy
08/07/2003US20030147904 Novel 13-transmembrane protein expressed in prostate cancer
08/07/2003US20030147903 ABC transport polynucleotides, polypeptides and antibodies
08/07/2003US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens
08/07/2003US20030147900 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes there of
08/07/2003US20030147897 M. tuberculosis antigens
08/07/2003US20030147895 Constructs for delivery of threrapeutic agents to neuronal cells
08/07/2003US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells
08/07/2003US20030147893 Novel human transmembrane 4 superfamily protein
08/07/2003US20030147892 Antibodies against rat pituitary tumor transforming gene carboxy-terminal (PTTG-C) peptides
08/07/2003US20030147891 Administering to a human patient at least one anti-TNF(tumor necrosis factor) monoclonal antibody, or a TNF binding fragment for treating neurodegenerative diseases
08/07/2003US20030147890 Administering a monoclonal antibody which is a murine anti-human IL-8 monoclonal antibody, for treating skin inflammatory diseases
08/07/2003US20030147889 Administering type 1-interferon antibody, for inhibition of prevention of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, type 1 diabetes, multiple sclerosis and psoriasis
08/07/2003US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies
08/07/2003US20030147886 Novel antibody compositions for preparing enriched dendritic cell preparations
08/07/2003US20030147885 Administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies for treating B cell lymphoma
08/07/2003US20030147884 Administering a breast cancer patient (caused by human ErbB2 oncogene which codes a transmebrane glycoprotein receptor related to epidermal growth factor receptor, is overexpressed) an anti ErbB2 antibody and a drug
08/07/2003US20030147883 Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection
08/07/2003US20030147882 Administering to the patient an effective dose of an immunoglobulin polypeptide or fragment which binds to an amyloid fibril, thus enhance cellular immune response of a patient to remove diseased amyloid fibril deposit
08/07/2003US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy
08/07/2003US20030147879 Method of improving wound healing
08/07/2003US20030147878 Tissue treatment compositions
08/07/2003US20030147877 Method for vitreous liquefaction
08/07/2003US20030147876 Combination of a growth factor and a protease enzyme
08/07/2003US20030147875 Sulfatases and methods of use thereof
08/07/2003US20030147874 A targeted beta-lactamase enzyme can converting a prodrug to a drug product; used as antiproliferative disorder, anticarcinogenic agent treating cancer, treating autoimmune disease or infectious diseases
08/07/2003US20030147871 An immunotherapy by administering two engineered mammalian cells that each expresses IL-12 and IL-18 interleukins; synergistic response; antitumor treatment
08/07/2003US20030147868 A gene therapy, transfecting cells with exogenous genetic DNA for coding a desired therapeutic proteins, culturing the cells, for large-scale protein production
1 ... 1797 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 ... 3163